190 related articles for article (PubMed ID: 15968953)
21. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients.
Mohammadpour AH; Nazemian F; Khaiat MH; Tafaghodi M; Salari P; Charkazi S; Naghibi M; Shamsara J
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):73-8. PubMed ID: 24434385
[TBL] [Abstract][Full Text] [Related]
22. Reduced requirement for erythropoietin with quotidian hemodialysis therapy.
Klarenbach S; Heidenheim AP; Leitch R; Lindsay RM;
ASAIO J; 2002; 48(1):57-61. PubMed ID: 11814098
[TBL] [Abstract][Full Text] [Related]
23. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure.
Di Iorio BR; Minutolo R; De Nicola L; Bellizzi V; Catapano F; Iodice C; Rubino R; Conte G
Kidney Int; 2003 Nov; 64(5):1822-8. PubMed ID: 14531817
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
[TBL] [Abstract][Full Text] [Related]
26. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
27. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep.
Chan CT; Hanly P; Gabor J; Picton P; Pierratos A; Floras JS
Kidney Int; 2004 Feb; 65(2):661-5. PubMed ID: 14717939
[TBL] [Abstract][Full Text] [Related]
28. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
[TBL] [Abstract][Full Text] [Related]
29. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin.
Moreno F; Aracil FJ; Pérez R; Valderrábano F
Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066
[TBL] [Abstract][Full Text] [Related]
30. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
Sultana T; DeVita MV; Michelis MF
Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339
[TBL] [Abstract][Full Text] [Related]
31. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
32. [Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].
Poveda Gómez F; Camacho Siles J; Quevedo Morales E; Fernández Zamorano A; Codoceo Alquinta R; Arnalich Fernández F; Sempere Alcocer M
An Med Interna; 2001 Jun; 18(6):298-304. PubMed ID: 11503575
[TBL] [Abstract][Full Text] [Related]
33. The acute effect of intravenously administered recombinant human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis.
William J; Saad N; Salib M; Riad H; Mahran KS; Iskander I; Cozma G; Barsoum R
Artif Organs; 1998 Mar; 22(3):192-6. PubMed ID: 9527278
[TBL] [Abstract][Full Text] [Related]
34. [The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial].
Chen N; Qian JQ; Mei CL; Zhang AH; Xing CY; Wang L; Liu WH; Wang M; Chen JH; Liu BC; Hou FF; Chen XM; Zuo L; Shi W; Yu LB; Zhang Y
Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):502-7. PubMed ID: 22943819
[TBL] [Abstract][Full Text] [Related]
35. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients.
Bárány P; Divino Filho JC; Bergström J
Am J Kidney Dis; 1997 Apr; 29(4):565-8. PubMed ID: 9100046
[TBL] [Abstract][Full Text] [Related]
36. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.
Keven K; Kutlay S; Nergizoglu G; Ertürk S
Am J Kidney Dis; 2003 Jun; 41(6):1233-9. PubMed ID: 12776276
[TBL] [Abstract][Full Text] [Related]
37. Intensive Hemodialysis Preserved Cardiac injury.
Chan CT; Li GH; Valaperti A; Liu P
ASAIO J; 2015; 61(5):613-9. PubMed ID: 26164598
[TBL] [Abstract][Full Text] [Related]
38. Correction of hemodialysis anemia is associated with significant increase in serum concentration of IGF-I in patients treated with erythropoietin: a randomized controlled study.
Sheashaa HA; Khalil A; Aarman MM; El-Shahat FB; Selim A; El-Gawad SS
Int Urol Nephrol; 2005; 37(1):153-8. PubMed ID: 16132779
[TBL] [Abstract][Full Text] [Related]
39. Production of interleukin-10 in serum and erythropoietin sensitivity in ESRD patients on hemodialysis.
Attia FM; Tawfik GA; Kalil KA; Mossalam MF
Int J Lab Hematol; 2010 Oct; 32(5):524-9. PubMed ID: 20148986
[TBL] [Abstract][Full Text] [Related]
40. Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
Tonelli M; Blake PG; Muirhead N
ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
